Jul. 21, 2017

FDA Approves BENLYSTA as a Weekly Self-Administered Injection to Treat Lupus

Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.

Jun. 26, 2017

Lupus Activists Urge Congress to Support Research Funding, Access to Quality & Affordable Care

On June 27, nearly 200 lupus activists from across the country will visit Capitol Hill and thousands more will join virtually.

Mar. 21, 2017

The Lupus Foundation of America Receives Prestigious Advocacy Award From Research!America

We are committed to pushing the boundaries of scientific investigation and rallying stakeholders to channel resources toward research until we reach our vision of a life free of lupus.

Mar. 13, 2017

House Passes Defense Appropriations Bill with $5 Million for Lupus Research Program

Critical vote is big step toward establishing research program at DoD to help solve cruel mystery of lupus.

Mar. 13, 2017

Voclosporin Clinical Study Achieves High Complete Remission Rates for Lupus Nephritis

Aurinia Pharmaceuticals has announced top line results from a Phase IIb clinical study of volclosporin for the treatment of lupus nephritis.

Oct. 19, 2016

Our New Medicare Part D Enrollment Tool

A patient tool to help you better organize your prescription information.

Oct. 18, 2016

Lupus Foundation of America named 2017 Distinguished Advocacy Organization

Research!America has chosen the Foundation as the recipient of the Paul G. Rogers Distinguished Organization Advocacy Award.

Sep. 28, 2016

PhRMA Medicines in Development Report

The Pharmaceutical Research and Manufacturers of America's Medicines in Development Report cites 39 medicines in development for lupus.